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Genomics based Engineering for the 


































• founded Nov. 2009
• part of the
Helmholtz-Center for
Infection Research
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)
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Natural Products Research and Drug Discovery








A PERFECT STORM . . .
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“ … a significant number of natural product
drugs/leads are actually produced by microbes
and/or microbial interactions with the “host from
whence it was isolated”, and therefore we
consider that this area of natural product
research should be expanded significantly.“
Newman & Cragg, JNP 2012
„ “: NPs or NP-derived
Small Molecules
Cooper & Shlaes, Nature 2011
MYXOBACTERIA
Little studied because of
• slow growth
• difficult isolation procedure
• poorly established genetics
Advantages
• new compounds
• new modes of action




Little studied because of
• slow growth
• difficult isolation procedure
• poorly established genetics
Advantages
• new compounds
• new modes of action
• low risk of isolating
known compounds
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Weissman & Müller, NPR 2010
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Myxobacterial Strain Collection & Screening
> 8000 world-wide isolates
including recently identified novel
families, e.g. Phaselicystideae






















































coupled to biological assays
Activity of fractions
Fractionation









[M+H]+ = 416.3161 m/z













‘Myxo strain collection‘ Percentage showing activity in ‘Initial Screen’
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~ 1700 strains re-activated






























Currently 3 compounds belonging to 
completely novel structural classes
 2 active against MRSA
 1 active against Gram-negativesCriteria for further evaluation 







Argyrin – Lead structures for antibiotic development?
Test organism
A B C D
Bacillus subtilis DSM 10 0 0 0 0
Escherichia coli DSM 498 0 0 0 0
E. coli tolC GBF 9 8 0 0
Micrococcus luteus GBF 0 0 - 7
Mycobacterium phlei GBF 0 0 0 0








 Development of resistance?
Pseudomonas aeruginosa DSM1117 13 15 14 13
P. acidovorans GBF 16 15 15 14
Staphylococcus aureus GBF 7 0 7 0
Candida albicans CBS 1893 0 0 - -
Hansenula anomala DSM 70263 0 0 0 0
Metschnikowia pulcherrina DSM 70321 0 0 0 0
Botrytis cinerea DSM 877 12 13 11 0
Mucor hiemalis DSM 2655 0 0 - -
Pythium debaryanum DSM 62946 10 10 0 0
Sasse et al, J. Antibiot. 2002
Argyrin Resistance Mechanism & Bacterial Target
Several rounds of colony picking and
stepwise increase of argyrin concentrations
1. Generation of argyrin-resistant Pseudomonas aeruginosa mutants







3. In silico analysis of the genome data
for resistance mutations
2 x Wildtype DNA







Mutation in Elongation Factor G 
confers Argyrin Resistance 
Bielecki et al., submitted
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Elansolids A1 and A2: Stable Atropisomers with different activities












Steinmetz et al. (2011) Angew. Chem. Int. Ed. Engl.  50, 532.
Dehn et al. (2011) Angew. Chem. Int. Ed. Engl. 50, 3882; Jansen et al. (2012) Chemistry 17, 7739
+ New target 
- Very low plasma stability
presumably based on equilibrium:
Lactone/Quinone











- Activity slightly decreased
MICs 2 to 8 fold























8 X = H
18 X = Ph
19 X = o
20 X = o,p-difluorophenyl
21 X = p
22 X = p
23 X = p
10 X = H
11 X = OH
12 X = CO
2
13 X = CO2Me












First step towards drugs 
with optimized/ improved 
pharmaceutical properties 
Thuggacins from Sorangium cellulosum –












Thuggacins – Comparative Cluster Analysis Reveals 












So ce895) Cm c5)
Bock et al., Angew. Chem. Int. Ed., 2008; Buntin et al., Chem. Biol. 2010
Erb T J et al., PNAS. 2007
Primary metabolism: 
ethylmalonyl-CoA pathway, Rhodobacter sphaeroides
Crotonyl-CoA Carboxylase/Reductase (Ccr)
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In Vitro Studies on Generateion of the unusual Extender 
Unit: Reductive Carboxylation
TgaD catalyzes the 
reductive 
carboxylation










Buntin et al., Chem. Biol. 2010
Rachid S et al., ChembioChem. 2011
Buntin K et al., Chem.Biol. 2010
Unusual Alkylmalonyl thioester Building blocks by CCR
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Eustáquio AS et al., PNAS. 2009




Yoo et al Biosci Biotechnol
Biochem 2011
Wilsen et al., JACS 2011






Mo et al., JACS 2011
Qu et al., Mol Biosys 2011
CinECinC
AACP KS AT1 AT2 ACP C




Key to generation of unusal extender unit: hexylmalonyl-CoA:
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Rachid et al., ChemBioChem 2011
CinECinC
AACP KS AT1 AT2 ACP C


















Moore BS et al.,
Curr. Opin. Chem. Biol. 2008
Stereo image of quarternary
structure
Biosynthetic Studies and Enzyme Engineering: 
Structure of CinF as 2-octenoyl-CoA carboxylase/reductase
Asymmetric unit contains four CinF monomers 
in form of tetrameric dimer of dimers assembly.
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Biosynthetic Studies and Enzyme Engineering: 

















- Potential for engineering
CinF: 2-octenoyl-CoA Carboxylase/Reductase
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Quade N and Huo L et al., Nature Chem.Biol. 2012
Precursor-directed biosynthesis
HPLC-MS (EIC) chromatograms of extracts 
































Proposed Biosynthesis of the cyclo-hexenylanaline of salinosporamides:
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M. Nett et al., J.Med.Chem. 2009
cin
Streptomyces sp. JS360 – cosmid sequence
RII      T        S      R      Q   P   O    N  M       L     K   J                    A                 B       C      D      E      F      RI      H           I       
CinQ as a putative L-amino acid aminotransferase shows 80% similarity to SalW
Abolishment of cinnabaramide production in S. sp JS360::cinQ- mutant









































































Compounds 1 2 3 4 5 6*






*: S. Rachid et al., ChembioChem. 2011
Genome Mining: From Genes to Products
Biosynthetic gene cluster






















































PKS NRPS Hybrid Other
Number of clusters































Proteome17 of 18 clusters
are active!
Schley et al., J. Proteome Res., 2006
Bode et al., ChemBioChem, 2009





















Leinenbach et al., J. Prot. Res., 2009
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Introducing an improved analytical platform: LC-coupled
high-resolution electrospray mass spectrometry
EIC 
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Correlating genes to metabolites: 
Genomics and metabolomics for the discovery process
Myxalamid
M. xanthus DK1622













(# compounds) Discovery method
Analytical 
properties abundance
Myxalamide (4) genome-based Intense yellow very high
Myxochromide (3) genome-based Intense yellow high
Myxochelin (2) genome-based UV 254 nm high
Myxovirescin (3) genome-based MS 624 m/z fair
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Dkxanthene? c506
DKxanthene (11) transposon  
mutagenesis Intense yellow fair
c506 (8) NRPS/PKS metabolome mining 506.27132+ m/z low
c844 (1) NRPS metabolome mining 844.3742 m/z ultra low
c329 (1) PKS metabolome mining 329.1861 m/z ultra low
18 PKS/NRPS pathways
First Novel Secondary Metabolite found by
Metabolome Mining: Myxoprincomides








Strain A2: 38 x yield









Cortina et al., 
Angew. Chem. 2012
43.2 kbp gene (1.6 MDa protein)
A1 A2 A3 A4 A5 A6 A7 A8 A9 A10AT









Krug et al., AEM 2008
Genome Mining by Heterologous Expression
Engineering of biosynthetic gene clusters




























Wenzel et al., Chem. Biol. 2005 
 Time-consuming
 Labor-intense
 A matter of chance
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Genome Mining by Heterologous Expression
Engineering of biosynthetic gene clusters





























Wenzel et al., Chem. Biol. 2005 ; Fu et al., Nat. Biotech. 2012









 Without library construction 
and screening
 One round recombination
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Fu et al., Nat. Biotech. 2012      highlighted in Nat. Biotech and Nat. Methods
















































De novo Gene Cluster Synthesis for the Production of
bioactive Polyketides/nonribosomal Peptides 










of native gene cluster



















Epothilone B Epothilone D
PKS/NRPS assembly line
 10 Modules
 50 Catalytic domains
Design of an artificial Epothilone Pathway
Epothilone biosynthetic gene cluster (~ 60 kb)
Epothilone assembly line
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Cryptic splice sitesSlow codon clusters
Native gene cluster sequence
(from Sorangium cellulosum) 
Design of an artificial
gene cluster sequence
Artifical gene cluster sequence
(optimized for Myxococcus xanthus) 
Assembly of an artificial Epothilone Pathway
Total synthesis of modules
Epothilone biosynthetic gene cluster (~ 60 kb)
Epothilone assembly line
a1
Assembly of the gene cluster




4.6 kb 4.4 kb 6.3 kb 5.0 kb 4.6 kb 6.3 kb 7.5 kb 5.0 kb 7.0 kb 8.6 kb
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Assembly of an artificial Epothilone Pathway
Total synthesis of modules
Epothilone biosynthetic gene cluster (~ 60 kb)
Epothilone assembly line
a1 p1 b1 c1 c2 c3 d1 d2 e1c4














(in vivo & in vitro)
a1-p1-b1
Assembly of an artificial Epothilone Pathway
Total synthesis of modules
Epothilone biosynthetic gene cluster (~ 60 kb)
Epothilone assembly line
a1
Assembly of the gene cluster




4.6 kb 4.4 kb 6.3 kb 5.0 kb 4.6 kb 6.3 kb 7.5 kb 5.0 kb 7.0 kb 8.6 kb
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Unstable!
Assembly of an artificial Epothilone Pathway
Total synthesis of modules
Epothilone biosynthetic gene cluster (~ 60 kb)
Epothilone assembly line
a1
Assembly of the gene cluster









mediated by an artificial Biosynthetic Gene Cluster









Base Peak m/z = 478,26074-478,26360 


























302,28 416,14320,32238,20 262,19 354,24 442,17 469,43
478,27@cid35,00 



















Functional Genomics for novel Anti-Infectives
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 . . .
Structure & Yield optimization
How are these compounds made?
 Identify biosynthetic pathways
(Bacterial genomics)
 Study biosynthesis & gene regulation? ??
X
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How can we engineer production?
 Manipulate the producer strains
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